DHSC launches study into coronavirus (COVID-19) vaccines for pregnant women

DHSC launches study into coronavirus (COVID-19) vaccines for pregnant women

The Department of Health and Social Care (DHSC) has launched a clinical trial examining the best gap to leave between the first and second coronavirus (COVID-19) vaccines for pregnant women. This comes after a study involving 52,000 vaccinated pregnant women in England showed no safety concerns and the Joint Committee on Vaccination and Immunisation (JVCI) recommended the Pfizer/BioNTech and Moderna vaccines for pregnant women. The clinical trial, which is the country’s largest, is backed by £7.5m of government funding and is led by St George’s, University of London. They will test dose intervals between four to six weeks or eight to 12 weeks and will involve over 600 pregnant women, who will be between 13 and 34 weeks pregnant on the day of vaccination.

Vaccinations will begin in mid-August 2021. Applications for volunteers opened on 3 August 2021 with recruited participants to be invited via the NHS COVID-19 Vaccine Research Registry. The trials will run across 13 sites, all of which will involve participants from a wide range of backgrounds, including those from ethnic minorities.

Volunteers can sign up here.

Source: New study into COVID-19 vaccine dose interval for pregnant women

Related Articles:
Latest Articles: